AP
Astrocyte Pharmaceuticals develops neuroprotective therapies targeting traumatic brain injuries, concussions, and stroke by harnessing the therapeutic potential of astrocytes and glial cells. Their approach aims to enhance brain recovery and repair mechanisms, addressing the critical need for effective treatments in a leading cause of death and disability worldwide.
Updated 2 months ago
Funding
$6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Astrocyte Pharmaceuticals develops neuroprotective therapies targeting traumatic brain injuries, concussions, and stroke by harnessing the therapeutic potential of astrocytes and glial cells. Their approach aims to enhance brain recovery and repair mechanisms, addressing the critical need for effective treatments in a leading cause of death and disability worldwide.